MRgFUS
Showing 1 - 25 of 114
Movement Disorders Trial in Beijing (MRgFUS treatment)
Not yet recruiting
- Movement Disorders
- MRgFUS treatment
-
Beijing, ChinaChinese PLA General Hospital
Nov 17, 2022
ET and PD Patients Subjected With MRgFUS Thalamotomy
Active, not recruiting
- Movement Disorders
-
Beijing, ChinaJiaji Lin
Nov 12, 2022
Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Pembrolizumab
- Exablate MRgFUS + neoadjuvant pembolizumab
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
High Grade Glioma Trial in Phoenix (SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS))
Recruiting
- High Grade Glioma
- SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
- MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Dec 22, 2022
Movement Disorders, Essential Tremor, Holmes Tremor Trial in Toronto (Transcranial ExAblate System)
Active, not recruiting
- Movement Disorders
- +8 more
- Transcranial ExAblate System
-
Toronto, Ontario, Canada
- +1 more
Dec 19, 2022
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Essential Tremor Trial in Toronto (MRgFUS thalamotomy)
Recruiting
- Essential Tremor
- MRgFUS thalamotomy
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
May 17, 2022
Parkinson Disease, Neurologic Manifestations Trial in Móstoles (Exablate Bilateral Subthalamotomy)
Active, not recruiting
- Parkinson Disease
- Neurologic Manifestations
- Exablate Bilateral Subthalamotomy
-
Móstoles, Madrid, SpainHospital Universitario HM Puerta Del Sur. CINAC
Aug 2, 2022
Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound
Recruiting
- Undifferentiated Pleomorphic Sarcoma
- ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Secondary Bone Cancer, Bone Metastases Trial in Rome (Bone Metastases Pain treatment)
Completed
- Secondary Bone Cancer
- Bone Metastases
- Bone Metastases Pain treatment
-
Rome, Italy
- +1 more
Feb 1, 2022
Multimodal MRI for MRgFUS Central Lateral Thalamotomy in
Recruiting
- Neuropathic Pain
- Magnetic Resonance Imaging
- MRgFUS central lateral thalamotomy
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 15, 2021
Breast Cancer Trial in Salt Lake City (Muse MRgFUS System)
Recruiting
- Breast Cancer
- Muse MRgFUS System
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Aug 2, 2022
Tremor, Essential, Parkinson's Disease Trial in New York (Automatic DRT/VIM target-recognition method using MR-SISET and ML
Recruiting
- Tremor, Essential
- Parkinson's Disease
- Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches
- Routine clinical MRI protocol
-
New York, New YorkNYU Langone
Nov 12, 2021
Trigeminal Neuropathic Pain Trial in Charlottesville (Transcranial ExAblate, Sham Transcranial ExAblate)
Active, not recruiting
- Trigeminal Neuropathic Pain
- Transcranial ExAblate
- Sham Transcranial ExAblate
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Uterine Fibroids Trial in Germany (Magnetic Resonance Imaging-controlled high-focussed ultrasound therapy, Myomectomy
Recruiting
- Uterine Fibroids
- Magnetic Resonance Imaging-controlled high-focussed ultrasound therapy
- Myomectomy (laparoscopic or open surgical)
-
Frankfurt, Hessen, Germany
- +3 more
Dec 29, 2022
Resistant Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- Magnetic Resonance Imaging
- MR-guided focused ultrasound
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 31, 2021
Parkinson's Disease Trial in United States (ExAblate Transcranial System)
Completed
- Parkinson's Disease
- ExAblate Transcranial System
-
Stanford, California
- +4 more
Dec 20, 2021
Diffuse Intrinsic Pontine Glioma Trial in Phoenix, San Francisco, Washington (SONALA-001 (ALA) and MR-Guided Focused Ultrasound
Recruiting
- Diffuse Intrinsic Pontine Glioma
- SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, Arizona
- +2 more
Jan 4, 2023
Essential Tremor, Neurology Trial (Exablate Neuro Type 1.0 System with Echo Focusing)
Not yet recruiting
- Essential Tremor
- Neurology
- Exablate Neuro Type 1.0 System with Echo Focusing
- (no location specified)
Aug 3, 2022
Essential Tremor Trial in China, Japan, Taiwan (MRgFUS treatment)
Recruiting
- Essential Tremor
- MRgFUS treatment
-
Beijing, Beijing, China
- +11 more
Sep 2, 2021
Parkinson Disease Trial in Móstoles (Exablate Subthalamotomy, Sham Exablate Subthalamotomy)
Active, not recruiting
- Parkinson Disease
- Exablate Subthalamotomy
- Sham Exablate Subthalamotomy
-
Móstoles, Madrid, SpainHospital Universitario HM Puerta Del Sur. CINAC
Aug 2, 2022
Epilepsy, Unspecified, Refractory (Medically) Trial in United States (MRgFUS Ablation of Epileptic Foci)
Recruiting
- Epilepsy
- Neuro Ablation - Functional
-
Stanford, California
- +3 more
Sep 7, 2022
Benign Centrally-Located Intracranial Tumors Trial in Washington, Miami (ExAblate 4000 System)
Recruiting
- Benign Centrally-Located Intracranial Tumors
- ExAblate 4000 System
-
Washington, District of Columbia
- +1 more
Aug 16, 2022
Amyotrophic Lateral Sclerosis Trial in Toronto (Blood-Brain Barrier opening with MRgFUS)
Unknown status
- Amyotrophic Lateral Sclerosis
- Blood-Brain Barrier opening with MRgFUS
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 7, 2021
Essential Tremor Trial in United States (Transcranial ExAblate)
Active, not recruiting
- Essential Tremor
- Transcranial ExAblate
-
Stanford, California
- +6 more
Dec 19, 2022